Submitted by admin on Tue, 02/12/2013 - 13:35
Immune Pharmaceuticals and EpiCept amend merger agreement to allow Immune to purchase up to $0.5 million new EpiCept common stock
KV Pharmaceutical to file quarterly report late
ViroPharma to participate In two upcoming healthcare investor conferences